Overview
GenCell BioSolutions is at the forefront of the biotechnology revolution, developing a unique platform that accelerates the development and production of vaccines. Our proprietary technology utilizes synthetic biology to enhance the speed and efficacy of vaccine formulations, catering to a growing demand for effective solutions against emerging infectious diseases. Since our inception, we have successfully completed our initial proof of concept, demonstrating the ability to produce prototype vaccines significantly faster than traditional methods. Our partnerships with leading research institutions and pharmaceutical companies have validated our approach, and we are currently in the process of securing additional collaborations to expand our impact. The investment we are seeking will enable us to scale our operations, hire essential talent, and refine our technology. We plan to enhance our research and development facilities to increase production capabilities and accelerate the validation of our vaccines through preclinical studies. We have identified a substantial market opportunity in the rapidly evolving vaccine landscape, projected to grow considerably due to increasing global…
Use of funds
The requested investment of $1,580,000 will be allocated as follows:
- Laboratory Expansion and Equipment: $800,000 to enhance our R&D facilities and purchase state-of-the-art equipment.
- Talent Acquisition: $500,000 for hiring specialized scientists and operational staff.
- Preclinical Trials: $200,000 for funding early-stage clinical trials.
- Marketing and Business Development: $80,000 to expand our market outreach and secure additional partnerships.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.